<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
<HTML><HEAD><TITLE>Molecular Cloning | Protocol 8 Print Version</TITLE>
<META http-equiv=Content-Type content="text/html; charset=windows-1251"><!--================== Designed and Developed by WriteDesign =================--><!--======================= Powered by RomeBlack, Inc. =======================--><!--=== Copyright 2000, 2001 Cold Spring Harbor Labs. All Rights Reserved. ===-->
<META content="" name=keywords>
<META 
content="Two methods of screening pools of cloned cDNAs are discussed: transfection into mammalian cells and injection into Xenopus oocytes." 
name=description>
<META content="MSHTML 5.50.4134.600" name=GENERATOR></HEAD>
<BODY bgColor=#ffffff background=../izo/fon.gif>
<table width=600 border="0" cellspacing="0" cellpadding="0"><tr><td width=600><IMG height=49 hspace=4 src="../izo/logo_csh.gif" 
width=169 align=left vspace=4><IMG height=49 hspace=4 
src="../izo/print_header.gif" width=293 align=left vspace=4><BR 
clear=all><BR><FONT face="arial,verdana, helvetica" size=4><STRONG>Chapter 11, 
Protocol 8</STRONG></FONT><BR><BR clear=all><FONT face=arial,verdana,helvetica 
size=3><STRONG>Construction and Screening of Eukaryotic Expression 
Libraries<BR>Stage 2: Screening cDNA Libraries Constructed in Eukaryotic 
Expression Vectors</STRONG></FONT><BR><BR><FONT face="arial,verdana, helvetica" 
size=2>Two methods of screening pools of cloned cDNAs are discussed: 
transfection into mammalian cells and injection into <I>Xenopus</I> 
oocytes.</FONT> <BR><BR>
<TABLE border=1>
  <TBODY>
  <TR>
    <TD width=700><IMG height=11 alt=CSH hspace=4 src="../izo/triangle.gif" 
      width=11 border=0><FONT face=arial,verdana,helvetica 
      size=2><STRONG>CAUTION</STRONG></FONT><BR><IMG height=12 alt="" hspace=4 
      src="../izo/circle.gif" width=12 border=0><FONT 
      face="arial,verdana, helvetica" size=2> <STRONG>RECIPE</STRONG></FONT> 
  </TD></TR></TBODY></TABLE><BR><BR><FONT face=arial,verdana,helvetica 
size=3><STRONG>MATERIALS</STRONG></FONT><BR><BR>
<TABLE cellPadding=0 cellborder="0">
  <TBODY>
  <TR>
    <TD vAlign=top align=left><FONT face="arial,verdana, helvetica" 
      size=2><STRONG>Buffers and Solutions</STRONG></FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2>SM</FONT> <IMG 
      height=12 alt="" hspace=4 src="../izo/circle.gif" width=12 border=0> 
  </TD></TR>
  <TR>
    <TD><IMG height=10 src="../izo/spacer.gif" width=1 border=0></TD></TR>
  <TR>
    <TD vAlign=top align=left><FONT face="arial,verdana, helvetica" 
      size=2><STRONG>Enzymes and Buffers</STRONG></FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2>Restriction 
      endonucleases</FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2><I>Restriction 
      endonucleases will be required for certain procedures. Please see Steps 1 
      and 3.</I></FONT> </TD></TR>
  <TR>
    <TD><IMG height=10 src="../izo/spacer.gif" width=1 border=0></TD></TR>
  <TR>
    <TD vAlign=top align=left><FONT face="arial,verdana, helvetica" 
      size=2><STRONG>Nucleic Acids and Oligonucleotides</STRONG></FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2>cDNA library, 
      prepared as described in <A href="../11/07.htm">Chapter 
      11, Protocol 7</A></FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" 
      size=2>Transfection/Injection controls</FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2><I>Whenever 
      possible, choose a positive control cDNA that encodes a biological 
      activity similar to that of the desired target cDNA. The control cDNA is 
      used to establish the optimum pool size and to check that a given 
      transfection/injection experiment worked. The positive control cDNA should 
      be transferred into the appropriate strain of </I>E. coli<I> (if using a 
      plasmid expression vector) or packaged into bacteriophage <IMG 
      src="../izo/lambda.gif" border=0> before carrying out Step 
      1.</I><BR><I>Two types of negative controls should be included in 
      screening experiments using </I>Xenopus<I> oocytes: The plasmid vector 
      alone and the transcription reaction without added template 
      DNA.</I><BR><I>In addition, Step 1 requires either an empty bacteriophage 
      <IMG src="../izo/lambda.gif" border=0> expression vector packaged into 
      bacteriophage <IMG src="../izo/lambda.gif" border=0> particles or </I>E. 
      coli<I> transformed with the empty plasmid expression vector.</I></FONT> 
    </TD></TR>
  <TR>
    <TD><IMG height=10 src="../izo/spacer.gif" width=1 border=0></TD></TR>
  <TR>
    <TD vAlign=top align=left><FONT face="arial,verdana, helvetica" 
      size=2><STRONG>Media</STRONG></FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2>TB agar plates 
      containing the appropriate antibiotic</FONT> <IMG height=12 alt="" 
      hspace=4 src="../izo/circle.gif" width=12 border=0> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2>Terrific broth 
      (or other rich medium) containing the appropriate antibiotic</FONT> <IMG 
      height=12 alt="" hspace=4 src="../izo/circle.gif" width=12 border=0> 
  </TD></TR>
  <TR>
    <TD><IMG height=10 src="../izo/spacer.gif" width=1 border=0></TD></TR>
  <TR>
    <TD vAlign=top align=left><FONT face="arial,verdana, helvetica" 
      size=2><STRONG>Additional Reagents</STRONG></FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2>Steps 1 and 2 
      of this protocol may require a commercial plasmid purification kit (see <A href="../01/09.htm">Chapter 
      1, Protocol 9</A>).</FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2>Steps 1 and 3 
      of this protocol may require the reagents from one of the transfection 
      protocols in Chapter 16.</FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2>Steps 1 and 3 
      of this protocol may require the reagents listed in <A href="../09/06.htm">Chapter 
      9, Protocol 6</A>.</FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2>Steps 1 and 3 
      of this protocol may require the reagents necessary to inject mRNA 
      molecules into <I>Xenopus</I> oocytes.</FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2>Step 1 of this 
      protocol may require the reagents listed in <A href="../02/01.htm">Chapter 
      2, Protocol 1</A> or <A href="../02/05.htm">Chapter 
      2, Protocol 5</A> and <A href="../02/23.htm">Chapter 
      2, Protocol 23</A> or <A href="../02/24.htm">Chapter 
      2, Protocol 24</A>.</FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2>Step 1 of this 
      protocol requires the reagents necessary to assay for the biological 
      activity encoded by the positive control cDNA.</FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2>Step 2 of this 
      protocol may require the reagents listed in <A href="../01/26.htm">Chapter 
      1, Protocol 26</A>, and <A href="../02/01.htm">Chapter 
      2, Protocol 1</A> and <A href="../02/23.htm">Chapter 
      2, Protocol 23</A> or <A href="../02/24.htm">Chapter 
      2, Protocol 24</A>.</FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2>Step 4 of this 
      protocol requires the reagents necessary to assay for the biological 
      activity encoded by the target cDNA.</FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2>Step 6 of this 
      protocol requires the reagents listed in Chapter 7, Chapter 12, Chapter 
      15, and Chapter 16.</FONT> </TD></TR>
  <TR>
    <TD><IMG height=10 src="../izo/spacer.gif" width=1 border=0></TD></TR>
  <TR>
    <TD vAlign=top align=left><FONT face="arial,verdana, helvetica" 
      size=2><STRONG>Cells and Tissues</STRONG></FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2>Host 
      cells</FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2>Xenopus<I> 
      oocytes are taken from female South African clawed frogs, which are 
      available from several biological supply houses (such as Carolina 
      Biological Supply or Kons Scientific). Difficulties in expressing mRNAs 
      can sometimes be overcome by switching suppliers.</I><BR><I>Simian COS 
      cells or derivatives of the 293 line of human embryonic kidney cells are 
      the mammalian hosts of choice for transient expression of cloned cDNAs 
      because of their superior efficiencies of transfection. However, many 
      other cell lines have been used successfully (e.g., Chinese hamster ovary 
      and NIH-3T3).</I><BR><I>Before embarking on expression cloning, test 
      lysates of mock-injected oocytes or lysates of mock-transfected cells for 
      the activity of target protein. It is essential to start with an 
      expression host that has low to undetectable levels of the activity to be 
      cloned.</I></FONT> </TD></TR>
  <TR>
    <TD><IMG height=10 src="../izo/spacer.gif" width=1 
  border=0></TD></TR></TBODY></TABLE><BR><BR><FONT 
face="arial,verdana,&#13;&#10;    helvetica" 
size=3><STRONG>METHOD</STRONG></FONT> <BR><FONT face="arial,verdana, helvetica" 
color=#000000 size=2>
<OL>
  <LI><FONT face="arial,verdana, helvetica" color=#000000 size=2>Set up a series 
  of trial experiments to optimize the transfection and expression systems used 
  to screen the library for cDNA clones of interest. This is best done by using 
  a previously cloned cDNA encoding a biological activity for which reliable 
  assays are available.<BR><BR><B>If a eukaryotic plasmid expression vector and 
  cultured cell host are used</B> 
  <TABLE>
    <TBODY>
    <TR>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>a.</FONT></TD>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>Inoculate a 
        single colony of <I>E. coli</I> harboring a plasmid carrying the cDNA 
        used as a positive control into 10 ml of rich medium (e.g., Terrific 
        Broth containing a selective antibiotic) together with 10, 100, 1000, 
        10,000, or 100,000 colonies derived from electroporation of <I>E. 
        coli</I> with an empty vector. Grow the cells to saturation in an 
        overnight culture incubated with agitation at 37°C.</FONT></TD></TR>
    <TR>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>b.</FONT></TD>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>Use a 
        commercial kit to prepare plasmid DNA of a purity sufficient for 
        efficient transfection of cultured mammalian cells (please see <A href="../01/09.htm">Chapter 
        1, Protocol 9</A>).</FONT></TD></TR>
    <TR>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>c.</FONT></TD>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>Use one or more 
        of the methods described in Chapter 16 to transfect the various plasmid 
        preparations into cultures of eukaryotic cells and assay for the 
        biological activity encoded by the positive control cDNA.<BR><I>When 
        screening the cDNA library, use the transfection method that generates 
        the maximum signal and an acceptably low level of 
      background.</I></FONT></TD></TR></TBODY></TABLE><BR><B>If a bacteriophage RNA 
  polymerase (e.g., T3, T7, or Sp6) is used to transcribe cDNAs from a plasmid 
  expression vector followed by <I>Xenopus</I> oocyte injection</B> 
  <TABLE>
    <TBODY>
    <TR>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>a.</FONT></TD>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>Follow Steps a 
        and b above.</FONT></TD></TR>
    <TR>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>b.</FONT></TD>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>Linearize the 
        pooled, purified plasmid DNAs at the rare restriction site placed at the 
        3' end of the cDNAs during library construction, and transcribe the 
        templates in vitro into mRNA (please see <A href="../09/06.htm">Chapter 
        9, Protocol 6</A>).</FONT></TD></TR>
    <TR>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>c.</FONT></TD>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>Inject the mRNA 
        prepared from the pooled cDNAs into <I>Xenopus</I> oocytes and assay the 
        appropriate biological activity or transfect the mRNA into the 
        appropriate cell line.</FONT></TD></TR></TBODY></TABLE><BR><B>If a 
  bacteriophage <IMG src="../izo/lambda.gif" border=0> vector containing 
  bacteriophage-encoded RNA polymerase promoters was chosen as an expression 
  vector</B> 
  <TABLE>
    <TBODY>
    <TR>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>a.</FONT></TD>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>Generate a set 
        of bacteriophage suspensions containing different ratios (10:1, 100:1, 
        1000:1, etc.) of an empty bacteriophage <IMG src="../izo/lambda.gif" 
        border=0> vector to a recombinant bacteriophage <IMG 
        src="../izo/lambda.gif" border=0> harboring the control cDNA. Infect 
        an appropriate strain of <I>E. coli</I> with a multiplicity of 
        bacteriophage particles that yields near-confluent lysis of bacterial 
        lawns or complete lysis of infected cells grown in liquid culture 
        (please see <A href="../02/01.htm">Chapter 
        2, Protocol 1</A> or <A href="../02/05.htm">Chapter 
        2, Protocol 5</A>).</FONT></TD></TR>
    <TR>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>b.</FONT></TD>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>Prepare 
        bacteriophage <IMG src="../izo/lambda.gif" border=0> DNA from the 
        plates (please see <A href="../02/23.htm">Chapter 
        2, Protocol 23</A>) or from the liquid cultures (please see <A href="../02/24.htm">Chapter 
        2, Protocol 24</A>).</FONT></TD></TR>
    <TR>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>c.</FONT></TD>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>Linearize the 
        bacteriophage <IMG src="../izo/lambda.gif" border=0> DNA at the rare 
        restriction site placed at the 3' end of the cDNAs during library 
        construction, and transcribe the cDNAs into mRNA as described in <A href="../09/06.htm">Chapter 
        9, Protocol 6</A>.</FONT></TD></TR>
    <TR>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>d.</FONT></TD>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>Inject the 
        prepared mRNA into <I>Xenopus</I> oocytes, and assay the mRNAs for their 
        ability to encode the biological activity of the cDNA used as a positive 
        control.</FONT></TD></TR></TBODY></TABLE></FONT>
  <LI><FONT face="arial,verdana, helvetica" color=#000000 size=2>Using the 
  results obtained in Step 1 as a rough guide, divide the cDNA library into 
  pools of a suitable size for screening, and transform or transfect <I>E. 
  coli</I> with the expression library pools. Prepare plasmid or bacteriophage 
  <IMG src="../izo/lambda.gif" border=0> DNA that will be used to screen the 
  pools for the presence of the target cDNA.<BR><BR><B>If the expression library 
  is constructed in a plasmid vector and pools are grown on solid medium</B> 
  <TABLE>
    <TBODY>
    <TR>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>a.</FONT></TD>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>Withdraw a 
        sufficient number of aliquots (e.g., 50-100 aliquots, each capable of 
        generating approx. 1000 recombinants) from the ligation mixture (<A href="07.htm">Chapter 
        11, Protocol 7</A>, Step 8), and introduce each aliquot individually 
        into <I>E. coli</I> by electroporation. Plate the entire contents of 
        each electroporation cuvette onto a single dish of Terrific agar medium 
        containing the appropriate antibiotic. Incubate the plates overnight at 
        37°C.</FONT></TD></TR>
    <TR>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>b.</FONT></TD>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>Estimate the 
        number of colonies on each plate. Scrape the colonies from each plate 
        into 5 ml of rich medium (e.g., Terrific broth containing a selectable 
        antibiotic). Grow the bacterial suspensions to saturation, and then 
        prepare purified plasmid DNA for 
  screening.</FONT></TD></TR></TBODY></TABLE><BR><B>If the expression library is 
  constructed in a plasmid vector and pools are grown in liquid 
  medium</B><BR>The advantages of this procedure are that the plating step is 
  omitted, thus saving time and effort, and there is less chance that any 
  individual cDNA will be lost because of poor growth on agar, or because of 
  mechanical damage. 
  <TABLE>
    <TBODY>
    <TR>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>a.</FONT></TD>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>Withdraw a 
        sufficient number of aliquots (e.g., 50-100 aliquots, each capable of 
        generating approx. 1000 recombinants) from the ligation mixture (<A href="01.htm">Chapter 
        11, Protocol 1</A>, Step 8), and introduce them individually into 
        separate cultures of <I>E. coli</I> by electroporation. The number of 
        transformants should equal the desired pool size in each 
      culture.</FONT></TD></TR>
    <TR>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>b.</FONT></TD>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>Add 1 ml of 
        rich medium (e.g., SOC or Terrific broth) without antibiotics to each 
        bacterial culture immediately after electroporation. Incubate the 
        culture for 1 hour at 37°C with very gentle agitation.</FONT></TD></TR>
    <TR>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>c.</FONT></TD>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>Use an aliquot 
        of each bacterial culture to inoculate separate 5-ml cultures. After 
        growing the bacterial cultures to saturation, prepare purified plasmid 
        DNA for screening.</FONT></TD></TR></TBODY></TABLE><BR><B>If the expression 
  library is constructed in a bacteriophage <IMG src="../izo/lambda.gif" 
  border=0> vector and pools are to contain 10,000 to 100,000 cDNAs</B> 
  <TABLE>
    <TBODY>
    <TR>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>a.</FONT></TD>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>Plate an 
        appropriate volume of packaging mixture to produce a semiconfluent lawn 
        of recombinant bacteriophage plaques. Alternatively, use a sufficient 
        amount of packaging mixture to obtain complete lysis of <I>E. coli</I> 
        cells grown in liquid culture.</FONT></TD></TR>
    <TR>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>b.</FONT></TD>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>Isolate 
        bacteriophage <IMG src="../izo/lambda.gif" border=0> DNA by a plate 
        lysis procedure or a liquid culture procedure (please see <A href="../02/23.htm">Chapter 
        2, Protocol 23</A> or <A href="../02/24.htm">Chapter 
        2, Protocol 24</A>).</FONT></TD></TR></TBODY></TABLE><BR><B>If the expression 
  library is constructed in a bacteriophage <IMG src="../izo/lambda.gif" 
  border=0> vector and pools are to contain 10,000 or fewer cDNAs</B> 
  <TABLE>
    <TBODY>
    <TR>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>a.</FONT></TD>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>Plate 
        recombinant bacteriophages, equal in number to the pool size, at a 
        density of 1000 pfu per 100-mm dish.</FONT></TD></TR>
    <TR>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>b.</FONT></TD>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>When plaque 
        formation is complete, overlay each dish with 2-3 ml of SM to produce a 
        low-titer plate lysate. Calculate the titer of the lysate.</FONT></TD></TR>
    <TR>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>c.</FONT></TD>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>From the 
        low-titer plate lysate, produce a high-titer stock in liquid 
        culture.</FONT></TD></TR>
    <TR>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>d.</FONT></TD>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>Purify 
        bacteriophage <IMG src="../izo/lambda.gif" border=0> DNA by a liquid 
        culture procedure (please see <A href="../02/24.htm">Chapter 
        2, Protocol 24</A>).</FONT></TD></TR></TBODY></TABLE></FONT>
  <LI><FONT face="arial,verdana, helvetica" color=#000000 size=2>Transfer the 
  purified clone into the appropriate background to analyze for 
  expression:<BR>If the clone is purified plasmid DNA: Either transfect into 
  cultured mammalian cells or use as a template for in vitro synthesis of RNA by 
  a bacteriophage-encoded RNA polymerase, followed by injection into 
  <I>Xenopus</I> oocytes.<BR>If the clone is purified bacteriophage <IMG 
  src="../izo/lambda.gif" border=0> DNA: Linearize the DNA and use as a 
  template for in vitro synthesis of RNA, followed by injection into 
  <I>Xenopus</I> oocytes. </FONT>
  <LI><FONT face="arial,verdana, helvetica" color=#000000 size=2>Assay for the 
  biological activity encoded by the target cDNA. </FONT>
  <LI><FONT face="arial,verdana, helvetica" color=#000000 size=2>After a 
  positive pool(s) of cDNAs has been identified, subdivide and rescreen it in an 
  iterative fashion until a single cDNA encoding the target activity has been 
  identified. Carry out this goal, which is most easily accomplished using the 
  preparation of purified plasmid or bacteriophage <IMG 
  src="../izo/lambda.gif" border=0> DNA corresponding to the positive pool(s) 
  of recombinants, as follows: 
  <TABLE>
    <TBODY>
    <TR>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>a.</FONT></TD>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>Divide the 
        positive (primary) pool of plasmid or bacteriophage <IMG 
        src="../izo/lambda.gif" border=0> DNA into aliquots that generate 
        approximately one tenth of the original number of transformed colonies 
        or plaques.</FONT></TD></TR>
    <TR>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>b.</FONT></TD>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>Repeat Steps 3 
        and 4 above. Include the original positive pool as a positive control in 
        the rescreening assay.</FONT></TD></TR>
    <TR>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>c.</FONT></TD>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>Repeat the 
        process of subdivision until a single recombinant is obtained that 
        encodes the desired activity. Make sure that only single well-isolated 
        plaques or bacterial colonies are used to prepare bacteriophage or 
        plasmid DNA for the ultimate screen.</FONT></TD></TR></TBODY></TABLE></FONT>
  <LI><FONT face="arial,verdana, helvetica" color=#000000 size=2>Characterize 
  the single isolate that encodes the target activity by DNA sequencing (Chapter 
  12), expression (Chapter 15 or Chapter 16), and RNA blotting (Chapter 7). 
  </FONT></LI></OL></FONT><BR><BR><FONT 
face="arial,verdana,&#13;&#10;    helvetica" size=3><STRONG>RECIPES</STRONG> 
</FONT><IMG height=11 alt=CSH hspace=4 src="../izo/circle.gif" width=12 
border=0> <BR><BR>
<TABLE border=0>
  <TBODY>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD vAlign=top align=left width=400><FONT face=arial,verdana,helvetica 
      color=#000000 size=2><STRONG>Gelatin</STRONG></FONT> </TD></TR>
  <TR>
    <TD><IMG height=12 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>To prepare a 2% (w/v) 
      solution: Add 2 g of gelatin to a total volume of 100 ml of H<SUB>2</SUB>O 
      and autoclave the solution for 15 minutes at 15 psi (1.05 kg/cm 
      <SUP>2</SUP>) on liquid cycle.</FONT></TD></TR></TBODY></TABLE><BR>
<TABLE border=0>
  <TBODY>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD vAlign=top align=left width=400><FONT face=arial,verdana,helvetica 
      color=#000000 size=2><STRONG>Glycerol</STRONG></FONT> </TD></TR>
  <TR>
    <TD><IMG height=12 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>To prepare a 10% (v/v) 
      solution: Dilute 1 volume of molecular-biology-grade glycerol in 9 volumes 
      of sterile pure H<SUB>2</SUB>O. Sterilize the solution by passing it 
      through a prerinsed 0.22-µm filter. Store in 200-ml aliquots at 
    4°C.</FONT></TD></TR></TBODY></TABLE><BR>
<TABLE border=0>
  <TBODY>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD vAlign=top align=left width=400><FONT face=arial,verdana,helvetica 
      color=#000000 size=2><STRONG>Media Containing Agar or 
      Agarose</STRONG></FONT> </TD></TR>
  <TR>
    <TD><IMG height=12 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>
      <P>Prepare liquid media according to the recipes given. Just before 
      autoclaving, add one of the following:</P>
      <P>
      <TABLE>
        <TBODY>
        <TR>
          <TD><FONT face="arial, helvetica,verdana" size=2>Bacto Agar (for 
            plates)</FONT></TD>
          <TD><FONT face="arial, helvetica,verdana" size=2>15 
        g/liter</FONT></TD></TR>
        <TR>
          <TD><FONT face="arial, helvetica,verdana" size=2>Bacto Agar (for top 
            agar)</FONT></TD>
          <TD><FONT face="arial, helvetica,verdana" size=2>7 
        g/liter</FONT></TD></TR>
        <TR>
          <TD><FONT face="arial, helvetica,verdana" size=2>agarose (for 
            plates)</FONT></TD>
          <TD><FONT face="arial, helvetica,verdana" size=2>15 
        g/liter</FONT></TD></TR>
        <TR>
          <TD><FONT face="arial, helvetica,verdana" size=2>agarose (for top 
            agarose)</FONT></TD>
          <TD><FONT face="arial, helvetica,verdana" size=2>7 
        g/liter</FONT></TD></TR></TBODY></TABLE></P>
      <P>Sterilize by autoclaving for 20 minutes at 15 psi (1.05 kg/cm 
      <SUP>2</SUP>) on liquid cycle. When the medium is removed from the 
      autoclave, swirl it gently to distribute the melted agar or agarose evenly 
      throughout the solution. <I>Be careful!</I> The fluid may be superheated 
      and may boil over when swirled. Allow the medium to cool to 50-60°C before 
      adding thermolabile substances (e.g., antibiotics). To avoid producing air 
      bubbles, mix the medium by swirling. Plates can then be poured directly 
      from the flask; allow approx. 30-35 ml of medium per 90-mm plate. To 
      remove bubbles from medium in the plate, flame the surface of the medium 
      with a Bunsen burner before the agar or agarose hardens. Set up a color 
      code (e.g., two red stripes for LB-ampicillin plates; one black stripe for 
      LB plates, etc.) and mark the edges of the plates with the appropriate 
      colored markers.</P>
      <P>When the medium has hardened completely, invert the plates and store 
      them at 4°C until needed. The plates should be removed from storage 1-2 
      hours before they are used. If the plates are fresh, they will "sweat" 
      when incubated at 37°C. When this condensation drops on the agar/agarose 
      surface, it allows bacterial colonies or bacteriophage plaques to spread 
      and increases the chances of cross-contamination. This problem can be 
      avoided by wiping off the condensation from the lids of the plates and 
      then incubating the plates for several hours at 37°C in an inverted 
      position before they are used. Alternatively, remove the liquid by shaking 
      the lid with a single, quick motion. To minimize the possibility of 
      contamination, hold the open plate in an inverted position while removing 
      the liquid from the lid.</P></FONT></TD></TR></TBODY></TABLE><BR>
<TABLE border=0>
  <TBODY>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD vAlign=top align=left width=400><FONT face=arial,verdana,helvetica 
      color=#000000 size=2><STRONG>NaCl</STRONG></FONT> </TD></TR>
  <TR>
    <TD><IMG height=12 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>To prepare a 5 M 
      solution: Dissolve 292 g of NaCl in 800 ml of H<SUB>2</SUB>O. Adjust the 
      volume to 1 liter with H<SUB>2</SUB>O. Dispense into aliquots and 
      sterilize by autoclaving. Store the NaCl solution at room 
      temperature.</FONT></TD></TR></TBODY></TABLE><BR>
<TABLE border=0>
  <TBODY>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD vAlign=top align=left width=400><FONT face=arial,verdana,helvetica 
      color=#000000 size=2><STRONG>SM</STRONG></FONT> </TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>NaCl, 5.8 g</FONT></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" 
      size=2>MgSO<SUB>4</SUB>•7H<SUB>2</SUB>O, 2 g</FONT></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>1 M Tris-Cl (pH 7.5), 50 
      ml</FONT></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>H<SUB>2</SUB>O, to 1 
      liter</FONT></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>Gelatin</FONT></TD></TR>
  <TR>
    <TD><IMG height=12 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>If needed, add 5 ml 
      gelatin solution (2%). Sterilize the buffer by autoclaving for 20 minutes 
      at 15 psi (1.05 kg/cm<SUP>2</SUP>) on liquid cycle. After the solution has 
      cooled, dispense 50-ml aliquots into sterile containers. SM may be stored 
      indefinitely at room temperature. Discard each aliquot after use to 
      minimize the chance of contamination.</FONT></TD></TR></TBODY></TABLE><BR>
<TABLE border=0>
  <TBODY>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD vAlign=top align=left width=400><FONT face=arial,verdana,helvetica 
      color=#000000 size=2><STRONG>TB</STRONG></FONT> </TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>deionized H<SUB>2</SUB>O, 
      to 900 ml</FONT></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>glycerol, 4 
  ml</FONT></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>tryptone, 12 
  g</FONT></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>yeast extract, 24 
    g</FONT></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>For solid medium, please 
      see Media Containing Agar or Agarose.</FONT></TD></TR>
  <TR>
    <TD><IMG height=12 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>Shake until the solutes 
      have dissolved and then sterilize by autoclaving for 20 minutes at 15 psi 
      (1.05 kg/cm <SUP>2</SUP>) on liquid cycle. Allow the solution to cool to 
      60°C or less, and then add 100 ml of a sterile solution of 0.17 M 
      KH<SUB>2</SUB>PO<SUB>4</SUB>, 0.72 M K<SUB>2</SUB>HPO<SUB>4</SUB>. (This 
      solution is made by dissolving 2.31 g of KH<SUB>2</SUB>PO<SUB>4</SUB> and 
      12.54 g of K<SUB>2</SUB>HPO<SUB>4</SUB> in 90 ml of deionized 
      H<SUB>2</SUB>O. After the salts have dissolved, adjust the volume of the 
      solution to 100 ml with deionized H<SUB>2</SUB>O and sterilize by 
      autoclaving for 20 minutes at 15 psi [1.05 kg/cm <SUP>2</SUP>] on liquid 
      cycle.) </FONT></TD></TR></TBODY></TABLE><BR>
<TABLE border=0>
  <TBODY>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD vAlign=top align=left width=400><FONT face=arial,verdana,helvetica 
      color=#000000 size=2><STRONG>Terrific Broth</STRONG></FONT> </TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>deionized H<SUB>2</SUB>O, 
      to 900 ml</FONT></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>tryptone, 12 
  g</FONT></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>yeast extract , 24 
      g</FONT></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>glycerol, 4 
  ml</FONT></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>For solid medium, please 
      see Media Containing Agar or Agarose.</FONT></TD></TR>
  <TR>
    <TD><IMG height=12 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>Shake until the solutes 
      have dissolved and then sterilize by autoclaving for 20 minutes at 15 psi 
      (1.05 kg/cm<SUP>2</SUP>) on liquid cycle. Allow the solution to cool to 
      60°C or less, and then add 100 ml of a sterile solution of 0.17 M 
      KH<SUB>2</SUB>PO<SUB>4</SUB>, 0.72 M K<SUB>2</SUB>HPO<SUB>4</SUB>. (This 
      solution is made by dissolving 2.31 g of KH<SUB>2</SUB>PO<SUB>4</SUB> and 
      12.54 g of K<SUB>2</SUB>HPO<SUB>4</SUB> in 90 ml of deionized 
      H<SUB>2</SUB>O. After the salts have dissolved, adjust the volume of the 
      solution to 100 ml with deionized H<SUB>2</SUB>O and sterilize by 
      autoclaving for 20 minutes at 15 psi [1.05 kg/cm<SUP>2</SUP>] on liquid 
      cycle.)</FONT></TD></TR></TBODY></TABLE><BR>
<TABLE border=0>
  <TBODY>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD vAlign=top align=left width=400><FONT face=arial,verdana,helvetica 
      color=#000000 size=2><STRONG>Tris-Cl</STRONG></FONT> </TD></TR>
  <TR>
    <TD><IMG height=12 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>
      <P>Dissolve 121.1 g of Tris base in 800 ml of H<SUB>2</SUB>O. Adjust the 
      pH to the desired value by adding concentrated HCl.</P>
      <TABLE>
        <TBODY>
        <TR>
          <TD><FONT face=arial,helvetica,verdana size=2><I>pH</I></FONT> </TD>
          <TD width=4>&nbsp; </TD>
          <TD><FONT face=arial,helvetica,verdana size=2><I>HCl</I></FONT> 
        </TD></TR>
        <TR>
          <TD><FONT face=arial,helvetica,verdana size=2>7.4 </FONT></TD>
          <TD width=4>&nbsp; </TD>
          <TD><FONT face=arial,helvetica,verdana size=2>70 ml </FONT></TD></TR>
        <TR>
          <TD><FONT face=arial,helvetica,verdana size=2>7.6 </FONT></TD>
          <TD width=4>&nbsp; </TD>
          <TD><FONT face=arial,helvetica,verdana size=2>60 ml </FONT></TD></TR>
        <TR>
          <TD><FONT face=arial,helvetica,verdana size=2>8.0 </FONT></TD>
          <TD width=4>&nbsp; </TD>
          <TD><FONT face=arial,helvetica,verdana size=2>42 ml 
        </FONT></TD></TR></TBODY></TABLE>
      <P>(1 M) Allow the solution to cool to room temperature before making 
      final adjustments to the pH. Adjust the volume of the solution to 1 liter 
      with H<SUB>2</SUB>O. Dispense into aliquots and sterilize by 
      autoclaving.</P>
      <P>If the 1 M solution has a yellow color, discard it and obtain Tris of 
      better quality. The pH of Tris solutions is temperature-dependent and 
      decreases approx. 0.03 pH units for each 1°C increase in temperature. For 
      example, a 0.05 M solution has pH values of 9.5, 8.9, and 8.6 at 5°C, 
      25°C, and 37°C, 
respectively.</P></FONT></TD></TR></TBODY></TABLE><BR><BR><BR><BR><BR>
<OL></OL><BR><BR><BR><BR><BR><FONT face=Arial,Verdana,Helvetica 
size=1><STRONG>Copyright © 2000 by Cold Spring Harbor Laboratory Press. All 
rights reserved.</STRONG><BR>No part of these pages, either text or image may be 
used for any purpose other than personal use. Therefore, reproduction 
modification, storage in a retrieval system or retransmission, in any form or by 
any means, electronic, mechanical, or otherwise, for reasons other than personal 
use, is strictly prohibited without prior written 
permission.</FONT><BR><BR>
</td></tr></table>
</BODY></HTML>
